Copyright: ©Author(s) 2026.
World J Gastroenterol. May 7, 2026; 32(17): 117544
Published online May 7, 2026. doi: 10.3748/wjg.v32.i17.117544
Published online May 7, 2026. doi: 10.3748/wjg.v32.i17.117544
Table 13 Subgroup analysis of cardiovascular conditions
| CV disease | Outcome | HR | 95%CI | Nominal P value | Adjusted q value |
| IHD | Risk of PUB | 2.8 | 1.6-5.1 | 0.004 | 0.012 |
| CV events | 2.5 | 1.3-4.8 | 0.006 | 0.012 | |
| PCI | Risk of PUB | 1.8 | 1.2-2.7 | 0.045 | 0.068 |
| CV events | 1.5 | 1.1-2.1 | 0.042 | 0.068 | |
| CABG | Risk of PUB | 2 | 1.4-2.9 | 0.002 | 0.012 |
| CV events | 1.8 | 1.2-2.5 | 0.008 | 0.024 |
- Citation: Semeya AA, Makled WA, Elnagdy MA, Elgamal R, Othman AAA. Helicobacter pylori eradication and the prevention of peptic ulcer bleeding and cardiovascular disease progression in chronic aspirin users. World J Gastroenterol 2026; 32(17): 117544
- URL: https://www.wjgnet.com/1007-9327/full/v32/i17/117544.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i17.117544